Year: 2024

Verrica Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full-Year 2023 Financial Results on February 29, 2024

WEST CHESTER, Pa., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology...

CloudMD and Bristol Health Medical Group Announce the Launch of the Breakthrough Deviceless Remote Patient Monitoring Program

Bristol Health Embraces Innovation by Launching its Inaugural Remote Patient Monitoring Program Utilizing CloudMD's HealthyLYF PlatformVancouver, British Columbia--(Newsfile Corp. -...

Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Agreement with Futura Surgicare Pvt Ltd.

BELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), and Clinical Consultants International, LLC (“CCI”), a...

New England Journal of Medicine Publishes Results of Positive Randomized Phase 2 REVIVE Trial of Rusfertide in Treatment of Polycythemia Vera

- Trial met the primary efficacy endpoint achieving a clinically and statistically significant response in maintaining hematocrit control below 45%...

Safe Supply Commends B.C. Naturopathic Doctors Association’s Effort to Expand Prescription Powers Amid Substance-Use Crisis and Provides Update on Safety Strip Acquisition Transaction Details

NextGen Healthcare and SCHIO Team Up to Help California Providers Tackle the State’s New Data Exchange Regulations

HIE to Leverage Mirth Solutions to Give Californians Unprecedented Access to their Health RecordsREMOTE-FIRST COMPANY/SANTA CRUZ, Calif.--(BUSINESS WIRE)--#NextGenHealthcare--NextGen Healthcare today...

error: Content is protected !!